07:00 , May 7, 2015 |  BC Innovations  |  Distillery Therapeutics

Therapeutics: Importin 7 (IPO7); MAP kinase 1 (MAPK1; ERK-2); MAPK3 (ERK-1)

Cancer INDICATION: Cancer In vitro and mouse studies suggest a peptide inhibitor of IPO7 binding to MAPK1 or MAPK3 could help treat cancer. In multiple human cancer cell lines, a cell-penetrating peptide derived from MAPK1 and MAPK3...
07:00 , Jul 30, 2009 |  BC Innovations  |  Distillery Therapeutics

Indication: Cardiovascular disease

Indication Target/marker/pathway Summary Licensing status Publication and contact information Cardiovascular disease Hypertension Postmeiotic segregation...